Global RNAi Technologies Market to Reach $66.7 Billion by 2025: Analysis By Application, Therapeutics, Type & Geography - Research and Markets

RNAi Technologies Market Analysis & Trends - Industry Forecast to 2025"

report has been added to Research and Markets' offering.

The Global RNAi Technologies Market is poised to grow at a CAGR of
around 20.4% over the next decade to reach approximately $66.75 billion
by 2025.

This industry report analyzes the global markets for RNAi Technologies
across all the given segments on global as well as regional levels
presented in the research scope. The study provides historical market
data for 2013, 2014 revenue estimations are presented for 2015 and
forecasts from 2016 till 2025.

The study focuses on market trends, leading players, supply chain
trends, technological innovations, key developments, and future
strategies. With comprehensive market assessment across the major
geographies such as North America, Europe, Asia Pacific, Middle East,
Latin America and Rest of the world the report is a valuable asset for
the existing players, new entrants and the future investors.

The study presents detailed market analysis with inputs derived from
industry professionals across the value chain. A special focus has been
made on 23 countries such as U.S., Canada, Mexico, U.K., Germany, Spain,
France, Italy, China, Brazil, Saudi Arabia, South Africa, etc.

Key Trends:

  • Rise in number of genetic and metabolic disorders
  • Improvement in synthetic delivery carriers and chemical modifications
    to RNA
  • Recent Technological Developments of RNAi Technologies

Companies Mentioned:

  • Alnylam Pharmaceuticals
  • Benitec Biopharma Ltd
  • Biogen Idec, Inc.
  • F. Hoffmann-La Roche Ag
  • Filmtec Corporation
  • General Electric Co.
  • Ionis Pharmaceuticals
  • Monsanto Co.
  • Nitto Denko Corp.
  • Quark Pharmaceuticals Inc.
  • Rosetta Genomics Ltd.
  • RXI Pharmaceuticals
  • Syngenta International Ag
  • Thermo Fisher Scientific, Inc

Key Topics Covered:

1 Market Outline

2 Executive Summary

3 Market Overview

4 RNAi Technologies Market, By Application

5 RNAi Technologies Market, By Therapeutics

6 RNAi Technologies Market, By Type

7 RNAi Technologies Market, By Geography

8 Leading Companies

For more information about this report visit


Research and Markets
Laura Wood, Senior Manager
E.S.T. Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call
For GMT Office Hours Call +353-1-416-8900
Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Topics: Genomics